Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for GATA3
Z-value: 1.84
Motif logo
Transcription factors associated with GATA3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GATA3
|
ENSG00000107485.11 | GATA binding protein 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GATA3 | hg19_v2_chr10_+_8096631_8096660 | 0.06 | 3.9e-01 | Click! |
Activity profile of GATA3 motif
Sorted Z-values of GATA3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_+_139871948 | 34.12 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr7_+_142498725 | 31.40 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
| chr2_-_89619904 | 30.20 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr2_-_89157161 | 27.24 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr2_-_89340242 | 26.56 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chrX_+_128913906 | 26.44 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
| chrX_+_38420623 | 25.71 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr2_-_89399845 | 25.35 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr2_+_89901292 | 24.43 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr2_+_90108504 | 24.26 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr2_-_89292422 | 23.19 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chrX_+_38420783 | 21.66 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
| chr2_-_89513402 | 21.32 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr16_+_23847339 | 20.23 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr6_-_33041378 | 20.12 |
ENST00000428995.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr1_+_26644441 | 19.84 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
| chr2_-_89310012 | 19.76 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr6_+_33043703 | 19.75 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr11_-_5248294 | 19.46 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr12_-_11548496 | 19.18 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
| chr12_-_11422630 | 18.86 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
| chr2_+_90139056 | 18.50 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr6_-_31514516 | 17.77 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr5_-_176056974 | 17.27 |
ENST00000510387.1
ENST00000506696.1 |
SNCB
|
synuclein, beta |
| chr5_+_150404904 | 16.83 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
| chr5_-_42825983 | 16.76 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr2_-_89459813 | 16.29 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr22_+_23040274 | 16.18 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr19_+_5681011 | 16.14 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
| chr22_+_23241661 | 16.04 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr8_-_27457494 | 15.91 |
ENST00000521770.1
|
CLU
|
clusterin |
| chr19_-_37701386 | 15.57 |
ENST00000527838.1
ENST00000591492.1 ENST00000532828.2 |
ZNF585B
|
zinc finger protein 585B |
| chr22_-_38699003 | 15.51 |
ENST00000451964.1
|
CSNK1E
|
casein kinase 1, epsilon |
| chr2_+_90198535 | 15.27 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr1_+_156123359 | 15.20 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr14_-_106209368 | 15.03 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr8_-_18871159 | 14.95 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr8_+_21911054 | 14.62 |
ENST00000519850.1
ENST00000381470.3 |
DMTN
|
dematin actin binding protein |
| chr5_-_141338627 | 14.56 |
ENST00000231484.3
|
PCDH12
|
protocadherin 12 |
| chr3_+_111718173 | 14.25 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
| chr9_+_74526384 | 14.22 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
| chr3_-_195310802 | 14.12 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr22_+_23264766 | 13.99 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr22_-_21213029 | 13.93 |
ENST00000572273.1
ENST00000255882.6 |
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha |
| chr16_+_23847267 | 13.88 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr19_-_49944806 | 13.75 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chr2_-_89417335 | 13.37 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr2_+_90121477 | 13.26 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr22_-_27620603 | 13.08 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
| chr1_-_153113927 | 13.04 |
ENST00000368752.4
|
SPRR2B
|
small proline-rich protein 2B |
| chr19_+_50922187 | 12.96 |
ENST00000595883.1
ENST00000597855.1 ENST00000596074.1 ENST00000439922.2 ENST00000594685.1 ENST00000270632.7 |
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related) |
| chr18_-_74701962 | 12.92 |
ENST00000585201.1
|
MBP
|
myelin basic protein |
| chr5_-_139944196 | 12.79 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
| chr12_-_45307711 | 12.77 |
ENST00000333837.4
ENST00000551949.1 |
NELL2
|
NEL-like 2 (chicken) |
| chr22_+_23247030 | 12.76 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr3_-_121379739 | 12.36 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
| chr7_+_72742178 | 12.32 |
ENST00000442793.1
ENST00000413573.2 ENST00000252037.4 |
FKBP6
|
FK506 binding protein 6, 36kDa |
| chrX_+_64708615 | 12.28 |
ENST00000338957.4
ENST00000423889.3 |
ZC3H12B
|
zinc finger CCCH-type containing 12B |
| chr12_-_91573132 | 12.25 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
| chr11_-_111781554 | 12.17 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
| chr14_-_106322288 | 12.14 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr3_-_138763734 | 12.00 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
| chr6_-_32095968 | 11.97 |
ENST00000375203.3
ENST00000375201.4 |
ATF6B
|
activating transcription factor 6 beta |
| chr19_-_36523709 | 11.93 |
ENST00000592017.1
ENST00000360535.4 |
CLIP3
|
CAP-GLY domain containing linker protein 3 |
| chr11_+_124609742 | 11.93 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
| chr8_-_27468842 | 11.92 |
ENST00000523500.1
|
CLU
|
clusterin |
| chr22_+_29876197 | 11.89 |
ENST00000310624.6
|
NEFH
|
neurofilament, heavy polypeptide |
| chr1_+_156123318 | 11.89 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr13_+_53226963 | 11.88 |
ENST00000343788.6
ENST00000535397.1 ENST00000310528.8 |
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
| chr6_+_32407619 | 11.80 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr1_+_156589051 | 11.74 |
ENST00000255039.1
|
HAPLN2
|
hyaluronan and proteoglycan link protein 2 |
| chr1_+_171810606 | 11.73 |
ENST00000358155.4
ENST00000367733.2 ENST00000355305.5 ENST00000367731.1 |
DNM3
|
dynamin 3 |
| chr4_-_46911223 | 11.63 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
| chr4_+_128554081 | 11.57 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
| chr6_-_31514333 | 11.57 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
| chr11_+_124609823 | 11.55 |
ENST00000412681.2
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
| chr19_-_50316489 | 11.50 |
ENST00000533418.1
|
FUZ
|
fuzzy planar cell polarity protein |
| chr14_-_106406090 | 11.44 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr22_+_22681656 | 11.37 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr1_+_153330322 | 11.36 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr15_+_43803143 | 11.34 |
ENST00000382031.1
|
MAP1A
|
microtubule-associated protein 1A |
| chrX_-_13835147 | 11.30 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
| chr12_-_15104040 | 11.27 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
| chr11_-_117748138 | 11.26 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr22_+_23229960 | 11.16 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr4_-_46911248 | 11.13 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
| chr7_+_100136811 | 11.13 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
| chr1_+_152635854 | 11.12 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
| chr16_+_222846 | 11.03 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr17_-_29624343 | 11.02 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
| chr12_+_79258444 | 11.01 |
ENST00000261205.4
|
SYT1
|
synaptotagmin I |
| chr14_+_75746781 | 11.01 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr3_-_126194707 | 10.98 |
ENST00000336332.5
ENST00000389709.3 |
ZXDC
|
ZXD family zinc finger C |
| chr6_+_31515337 | 10.97 |
ENST00000376148.4
ENST00000376145.4 |
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
| chr11_-_64510409 | 10.97 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr19_+_41903709 | 10.87 |
ENST00000542943.1
ENST00000457836.2 |
BCKDHA
|
branched chain keto acid dehydrogenase E1, alpha polypeptide |
| chrX_+_8433376 | 10.85 |
ENST00000440654.2
ENST00000381029.4 |
VCX3B
|
variable charge, X-linked 3B |
| chr18_-_53069419 | 10.81 |
ENST00000570177.2
|
TCF4
|
transcription factor 4 |
| chr11_-_111781610 | 10.76 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr18_-_47813940 | 10.75 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
| chr7_+_72742162 | 10.74 |
ENST00000431982.2
|
FKBP6
|
FK506 binding protein 6, 36kDa |
| chr11_-_111782696 | 10.74 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
| chr9_-_130712995 | 10.70 |
ENST00000373084.4
|
FAM102A
|
family with sequence similarity 102, member A |
| chrX_+_16737718 | 10.68 |
ENST00000380155.3
|
SYAP1
|
synapse associated protein 1 |
| chr11_-_111794446 | 10.66 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
| chr9_+_139874683 | 10.66 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr17_+_4843413 | 10.64 |
ENST00000572430.1
ENST00000262482.6 |
RNF167
|
ring finger protein 167 |
| chr19_-_50316517 | 10.58 |
ENST00000313777.4
ENST00000445575.2 |
FUZ
|
fuzzy planar cell polarity protein |
| chr3_-_15140629 | 10.58 |
ENST00000507357.1
ENST00000449050.1 ENST00000253699.3 ENST00000435849.3 ENST00000476527.2 |
ZFYVE20
|
zinc finger, FYVE domain containing 20 |
| chr12_-_71182695 | 10.54 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
| chr15_+_74422585 | 10.50 |
ENST00000561740.1
ENST00000435464.1 ENST00000453268.2 |
ISLR2
|
immunoglobulin superfamily containing leucine-rich repeat 2 |
| chr12_-_11508520 | 10.43 |
ENST00000545626.1
ENST00000500254.2 |
PRB1
|
proline-rich protein BstNI subfamily 1 |
| chr2_+_90060377 | 10.43 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr7_+_24323782 | 10.42 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
| chr9_+_124088860 | 10.23 |
ENST00000373806.1
|
GSN
|
gelsolin |
| chr19_+_40854559 | 10.22 |
ENST00000598962.1
ENST00000409419.1 ENST00000409587.1 ENST00000602131.1 ENST00000409735.4 ENST00000600948.1 ENST00000356508.5 ENST00000596682.1 ENST00000594908.1 |
PLD3
|
phospholipase D family, member 3 |
| chr16_-_30032610 | 10.20 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
| chr14_-_106092403 | 10.17 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
| chrX_+_103031421 | 10.11 |
ENST00000433491.1
ENST00000418604.1 ENST00000443502.1 |
PLP1
|
proteolipid protein 1 |
| chr4_-_109684120 | 10.05 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
| chr3_-_16524357 | 10.00 |
ENST00000432519.1
|
RFTN1
|
raftlin, lipid raft linker 1 |
| chr11_-_111782484 | 9.96 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
| chr19_-_18314836 | 9.95 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
| chr16_+_55542910 | 9.94 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
| chr19_+_58694396 | 9.93 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
| chr14_-_106237742 | 9.91 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
| chr17_+_33448593 | 9.90 |
ENST00000158009.5
|
FNDC8
|
fibronectin type III domain containing 8 |
| chr14_+_29236269 | 9.89 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
| chr2_+_131769256 | 9.85 |
ENST00000355771.3
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4 |
| chr12_+_93772402 | 9.78 |
ENST00000546925.1
|
NUDT4
|
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
| chr11_+_118215036 | 9.73 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
| chr1_+_46972668 | 9.71 |
ENST00000371956.4
ENST00000360032.3 |
DMBX1
|
diencephalon/mesencephalon homeobox 1 |
| chr12_-_11422739 | 9.71 |
ENST00000279573.7
|
PRB3
|
proline-rich protein BstNI subfamily 3 |
| chr11_-_117747607 | 9.69 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr1_+_160097462 | 9.68 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr17_+_77681075 | 9.68 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
| chr12_+_79258547 | 9.65 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
| chr2_+_90077680 | 9.64 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr4_-_84406218 | 9.61 |
ENST00000515303.1
|
FAM175A
|
family with sequence similarity 175, member A |
| chr9_-_115818951 | 9.58 |
ENST00000553380.1
ENST00000374227.3 |
ZFP37
|
ZFP37 zinc finger protein |
| chr3_+_14989186 | 9.57 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
| chr7_-_37488834 | 9.57 |
ENST00000310758.4
|
ELMO1
|
engulfment and cell motility 1 |
| chr1_-_203151933 | 9.54 |
ENST00000404436.2
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39) |
| chr5_+_156693159 | 9.51 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr22_+_23101182 | 9.51 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr19_+_16435625 | 9.50 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr17_-_26903900 | 9.43 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
| chrX_-_57937067 | 9.41 |
ENST00000358697.4
|
ZXDA
|
zinc finger, X-linked, duplicated A |
| chr3_+_10068095 | 9.39 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
| chrX_-_6453159 | 9.39 |
ENST00000381089.3
ENST00000398729.1 |
VCX3A
|
variable charge, X-linked 3A |
| chr19_-_55668093 | 9.38 |
ENST00000588882.1
ENST00000586858.1 |
TNNI3
|
troponin I type 3 (cardiac) |
| chr1_+_151254738 | 9.25 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
| chrX_+_55478538 | 9.23 |
ENST00000342972.1
|
MAGEH1
|
melanoma antigen family H, 1 |
| chr6_+_7108210 | 9.23 |
ENST00000467782.1
ENST00000334984.6 ENST00000349384.6 |
RREB1
|
ras responsive element binding protein 1 |
| chr19_-_37019136 | 9.22 |
ENST00000592282.1
|
ZNF260
|
zinc finger protein 260 |
| chr11_+_1889880 | 9.20 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
| chrX_-_1572629 | 9.17 |
ENST00000534940.1
|
ASMTL
|
acetylserotonin O-methyltransferase-like |
| chrY_-_16098393 | 9.16 |
ENST00000250825.4
|
VCY
|
variable charge, Y-linked |
| chr6_-_62996066 | 9.15 |
ENST00000281156.4
|
KHDRBS2
|
KH domain containing, RNA binding, signal transduction associated 2 |
| chr7_-_5553369 | 9.15 |
ENST00000453700.3
ENST00000382368.3 |
FBXL18
|
F-box and leucine-rich repeat protein 18 |
| chr22_-_17680472 | 9.07 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
| chr12_-_54121261 | 9.06 |
ENST00000549784.1
ENST00000262059.4 |
CALCOCO1
|
calcium binding and coiled-coil domain 1 |
| chr19_-_13617037 | 9.05 |
ENST00000360228.5
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
| chr14_-_21516590 | 9.03 |
ENST00000555026.1
|
NDRG2
|
NDRG family member 2 |
| chr6_-_33048483 | 9.02 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr6_+_31554636 | 9.00 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
| chr9_-_93405352 | 8.99 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr19_+_57999079 | 8.99 |
ENST00000426954.2
ENST00000354197.4 ENST00000523882.1 ENST00000520540.1 ENST00000519310.1 ENST00000442920.2 ENST00000523312.1 ENST00000424930.2 |
ZNF419
|
zinc finger protein 419 |
| chr6_-_84419101 | 8.97 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr22_+_23237555 | 8.96 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
| chr1_+_92632542 | 8.87 |
ENST00000409154.4
ENST00000370378.4 |
KIAA1107
|
KIAA1107 |
| chr10_-_99531709 | 8.87 |
ENST00000266066.3
|
SFRP5
|
secreted frizzled-related protein 5 |
| chr1_+_156124162 | 8.87 |
ENST00000368282.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr19_-_50316423 | 8.84 |
ENST00000528094.1
ENST00000526575.1 |
FUZ
|
fuzzy planar cell polarity protein |
| chr11_-_62477041 | 8.82 |
ENST00000433053.1
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
| chr12_-_11463353 | 8.82 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
| chr2_-_89266286 | 8.74 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
| chr2_-_85555086 | 8.71 |
ENST00000444342.2
ENST00000409232.3 ENST00000409015.1 |
TGOLN2
|
trans-golgi network protein 2 |
| chr10_-_75226166 | 8.69 |
ENST00000544628.1
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme |
| chr17_-_29641084 | 8.69 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr16_+_1756162 | 8.69 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
| chr2_-_136288113 | 8.66 |
ENST00000401392.1
|
ZRANB3
|
zinc finger, RAN-binding domain containing 3 |
| chr19_-_51527467 | 8.65 |
ENST00000593681.1
|
KLK11
|
kallikrein-related peptidase 11 |
| chr11_+_121447469 | 8.61 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr18_-_53303123 | 8.56 |
ENST00000569357.1
ENST00000565124.1 ENST00000398339.1 |
TCF4
|
transcription factor 4 |
| chr19_+_15852203 | 8.51 |
ENST00000305892.1
|
OR10H3
|
olfactory receptor, family 10, subfamily H, member 3 |
| chr5_-_139943830 | 8.50 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
| chr14_-_21493123 | 8.50 |
ENST00000556147.1
ENST00000554489.1 ENST00000555657.1 ENST00000557274.1 ENST00000555158.1 ENST00000554833.1 ENST00000555384.1 ENST00000556420.1 ENST00000554893.1 ENST00000553503.1 ENST00000555733.1 ENST00000553867.1 ENST00000397856.3 ENST00000397855.3 ENST00000556008.1 ENST00000557182.1 ENST00000554483.1 ENST00000556688.1 ENST00000397853.3 ENST00000556329.2 ENST00000554143.1 ENST00000397851.2 ENST00000555142.1 ENST00000557676.1 ENST00000556924.1 |
NDRG2
|
NDRG family member 2 |
| chr2_-_51259292 | 8.48 |
ENST00000401669.2
|
NRXN1
|
neurexin 1 |
| chr20_-_48532019 | 8.46 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
| chr16_+_58283814 | 8.41 |
ENST00000443128.2
ENST00000219299.4 |
CCDC113
|
coiled-coil domain containing 113 |
| chr19_+_18723660 | 8.39 |
ENST00000262817.3
|
TMEM59L
|
transmembrane protein 59-like |
| chr2_-_51259229 | 8.38 |
ENST00000405472.3
|
NRXN1
|
neurexin 1 |
| chr7_-_38671098 | 8.37 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
| chr10_+_74451883 | 8.35 |
ENST00000373053.3
ENST00000357157.6 |
MCU
|
mitochondrial calcium uniporter |
| chr3_-_49131473 | 8.32 |
ENST00000430979.1
ENST00000357496.2 ENST00000437939.1 |
QRICH1
|
glutamine-rich 1 |
| chr8_+_24772455 | 8.32 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
| chr2_+_17935383 | 8.32 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
| chr14_-_50065882 | 8.28 |
ENST00000539688.1
|
AL139099.1
|
Full-length cDNA clone CS0DK012YO09 of HeLa cells of Homo sapiens (human); Uncharacterized protein |
| chr5_-_39274617 | 8.23 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of GATA3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.4 | 34.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 9.3 | 27.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 7.7 | 30.9 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 7.5 | 22.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 7.2 | 43.1 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 6.7 | 20.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 6.7 | 20.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 6.5 | 26.0 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 6.0 | 18.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 5.5 | 16.6 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 5.5 | 21.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 5.1 | 25.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 4.8 | 38.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 4.4 | 21.9 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
| 4.4 | 17.5 | GO:0019046 | release from viral latency(GO:0019046) |
| 4.2 | 12.7 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 4.2 | 4.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
| 4.1 | 4.1 | GO:2000785 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
| 4.1 | 16.2 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 4.0 | 15.9 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 3.9 | 11.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 3.8 | 3.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 3.8 | 15.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
| 3.8 | 38.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 3.8 | 11.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 3.8 | 11.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 3.7 | 531.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 3.7 | 3.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 3.7 | 11.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 3.6 | 3.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 3.5 | 28.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 3.4 | 40.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 3.4 | 6.8 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 3.4 | 10.1 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 3.3 | 10.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.2 | 13.0 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 3.2 | 9.7 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 3.2 | 6.4 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
| 3.2 | 12.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.2 | 3.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 3.2 | 12.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 3.2 | 6.3 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of cytoplasmic transport(GO:1903650) |
| 3.1 | 3.1 | GO:0009798 | axis specification(GO:0009798) |
| 3.1 | 12.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 3.1 | 52.3 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 3.0 | 6.0 | GO:0007412 | axon target recognition(GO:0007412) |
| 3.0 | 53.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 2.9 | 17.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 2.9 | 8.7 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 2.8 | 8.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 2.8 | 8.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 2.8 | 22.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.8 | 8.3 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 2.7 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 2.7 | 5.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 2.7 | 8.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 2.6 | 18.5 | GO:0045007 | depurination(GO:0045007) |
| 2.6 | 10.4 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 2.6 | 12.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 2.5 | 10.1 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 2.5 | 5.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 2.5 | 7.5 | GO:0021586 | pons maturation(GO:0021586) |
| 2.5 | 5.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 2.5 | 24.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 2.5 | 9.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.4 | 4.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 2.4 | 7.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 2.4 | 2.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 2.4 | 2.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 2.4 | 11.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 2.3 | 11.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 2.3 | 9.3 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 2.3 | 9.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 2.3 | 2.3 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 2.3 | 4.5 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 2.2 | 9.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 2.2 | 4.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 2.2 | 8.9 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 2.2 | 11.0 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 2.2 | 12.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 2.1 | 17.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 2.1 | 14.9 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 2.1 | 8.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 2.1 | 6.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 2.1 | 6.4 | GO:1904640 | response to methionine(GO:1904640) |
| 2.1 | 4.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 2.1 | 6.3 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 2.1 | 21.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 2.1 | 6.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 2.1 | 10.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 2.1 | 6.2 | GO:0050906 | detection of stimulus involved in sensory perception(GO:0050906) |
| 2.1 | 8.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 2.0 | 6.1 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 2.0 | 10.2 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 2.0 | 8.2 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 2.0 | 6.1 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 2.0 | 8.1 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 2.0 | 4.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 2.0 | 12.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
| 2.0 | 31.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 2.0 | 5.9 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 2.0 | 7.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 2.0 | 7.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 2.0 | 13.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.0 | 21.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 2.0 | 39.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 1.9 | 13.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.9 | 34.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.9 | 7.6 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.9 | 5.7 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 1.9 | 5.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.9 | 9.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 1.9 | 22.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 1.9 | 3.7 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 1.8 | 9.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 1.8 | 3.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 1.8 | 10.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 1.8 | 5.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.8 | 7.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.8 | 7.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.8 | 3.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.8 | 5.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.8 | 5.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.8 | 19.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 1.8 | 30.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 1.7 | 8.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 1.7 | 17.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 1.7 | 19.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.7 | 8.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 1.7 | 6.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.7 | 1.7 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) regulation of histone H3-K14 acetylation(GO:0071440) |
| 1.7 | 5.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 1.7 | 5.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.7 | 3.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 1.7 | 8.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 1.7 | 5.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 1.7 | 5.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 1.7 | 18.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.7 | 5.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 1.7 | 27.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 1.7 | 1.7 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 1.7 | 10.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.7 | 6.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 1.7 | 5.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 1.7 | 1.7 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 1.7 | 10.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 1.6 | 4.9 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.6 | 4.9 | GO:0035441 | cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
| 1.6 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 1.6 | 6.4 | GO:0042335 | cuticle development(GO:0042335) |
| 1.6 | 4.8 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 1.6 | 6.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.6 | 6.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 1.6 | 1.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 1.6 | 9.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 1.6 | 19.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 1.6 | 40.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.6 | 4.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 1.6 | 12.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 1.6 | 3.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 1.5 | 4.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 1.5 | 1.5 | GO:0030317 | sperm motility(GO:0030317) |
| 1.5 | 6.1 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 1.5 | 7.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 1.5 | 6.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 1.5 | 3.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 1.5 | 4.5 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 1.5 | 1.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 1.5 | 4.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 1.5 | 4.4 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 1.4 | 2.9 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
| 1.4 | 21.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.4 | 1.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 1.4 | 5.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 1.4 | 7.2 | GO:0080009 | mRNA methylation(GO:0080009) |
| 1.4 | 1.4 | GO:0002588 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.4 | 2.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.4 | 8.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.4 | 2.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.4 | 7.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 1.4 | 5.6 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 1.4 | 7.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.4 | 25.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 1.4 | 9.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 1.4 | 4.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 1.4 | 4.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.4 | 5.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 1.4 | 4.1 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 1.4 | 4.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.4 | 5.5 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 1.4 | 4.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 1.4 | 6.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
| 1.4 | 4.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 1.4 | 6.8 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 1.3 | 5.4 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 1.3 | 16.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.3 | 4.0 | GO:1903487 | regulation of lactation(GO:1903487) |
| 1.3 | 1.3 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 1.3 | 10.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.3 | 6.6 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
| 1.3 | 4.0 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.3 | 9.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 1.3 | 2.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 1.3 | 3.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 1.3 | 2.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 1.3 | 7.8 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 1.3 | 3.9 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 1.3 | 2.6 | GO:0008272 | sulfate transport(GO:0008272) |
| 1.3 | 18.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.3 | 6.5 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 1.3 | 22.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.3 | 1.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.3 | 6.4 | GO:0070842 | aggresome assembly(GO:0070842) |
| 1.3 | 7.6 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 1.3 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
| 1.3 | 37.8 | GO:0045730 | respiratory burst(GO:0045730) |
| 1.3 | 3.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.3 | 3.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.3 | 3.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 1.3 | 42.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 1.2 | 5.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 1.2 | 8.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 1.2 | 2.5 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 1.2 | 6.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.2 | 2.5 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.2 | 11.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 1.2 | 9.8 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 1.2 | 11.0 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
| 1.2 | 6.1 | GO:0030070 | insulin processing(GO:0030070) |
| 1.2 | 4.9 | GO:0006304 | DNA modification(GO:0006304) |
| 1.2 | 3.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.2 | 6.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.2 | 4.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 1.2 | 18.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 1.2 | 3.6 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 1.2 | 3.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 1.2 | 4.8 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 1.2 | 7.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 1.2 | 3.6 | GO:1904647 | response to rotenone(GO:1904647) |
| 1.2 | 3.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
| 1.2 | 7.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 1.2 | 8.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 1.2 | 14.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 1.2 | 3.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 1.2 | 5.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 1.2 | 6.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.2 | 3.5 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.2 | 1.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 1.1 | 39.0 | GO:0008038 | neuron recognition(GO:0008038) |
| 1.1 | 9.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.1 | 5.7 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.1 | 11.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 1.1 | 2.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.1 | 13.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 1.1 | 5.6 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 1.1 | 2.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
| 1.1 | 5.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 1.1 | 3.3 | GO:1902019 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 1.1 | 3.3 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.1 | 5.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.1 | 3.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 1.1 | 11.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 1.1 | 6.5 | GO:0099612 | protein localization to axon(GO:0099612) |
| 1.1 | 21.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 1.1 | 3.2 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 1.1 | 2.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 1.1 | 9.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 1.1 | 3.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 1.1 | 3.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.1 | 3.2 | GO:1904800 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 1.1 | 12.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 1.1 | 6.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.1 | 5.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 1.1 | 5.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 1.0 | 3.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.0 | 1.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 1.0 | 2.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 1.0 | 6.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 1.0 | 3.1 | GO:2000078 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 1.0 | 2.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 1.0 | 5.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 1.0 | 3.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 1.0 | 2.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 1.0 | 8.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 1.0 | 12.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 1.0 | 34.6 | GO:0090383 | phagosome acidification(GO:0090383) |
| 1.0 | 8.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.0 | 1.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 1.0 | 5.1 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.0 | 3.0 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 1.0 | 1.0 | GO:1901374 | acetate ester transport(GO:1901374) |
| 1.0 | 3.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.0 | 6.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 1.0 | 3.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.0 | 3.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 1.0 | 8.0 | GO:0046689 | response to mercury ion(GO:0046689) |
| 1.0 | 21.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 1.0 | 3.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.0 | 6.9 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 1.0 | 10.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 1.0 | 5.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 | 5.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 1.0 | 5.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 1.0 | 2.0 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 1.0 | 2.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 1.0 | 5.9 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 1.0 | 2.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 1.0 | 13.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 1.0 | 3.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.0 | 2.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.0 | 4.8 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.0 | 2.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.0 | 19.3 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 1.0 | 6.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 1.0 | 6.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 | 1.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 1.0 | 7.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 1.0 | 10.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 1.0 | 15.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 1.0 | 2.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 1.0 | 6.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 1.0 | 1.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.9 | 4.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.9 | 14.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.9 | 3.8 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.9 | 5.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.9 | 1.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.9 | 12.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.9 | 3.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.9 | 2.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.9 | 8.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.9 | 4.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.9 | 2.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.9 | 5.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.9 | 6.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.9 | 6.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.9 | 2.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.9 | 13.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.9 | 4.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 | 4.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.9 | 1.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.9 | 4.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.9 | 2.7 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.9 | 7.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.9 | 2.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.9 | 7.0 | GO:0021794 | thalamus development(GO:0021794) |
| 0.9 | 3.5 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.9 | 2.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.9 | 4.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.9 | 5.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.9 | 2.6 | GO:1904936 | cerebral cortex tangential migration(GO:0021800) cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.9 | 3.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.9 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.9 | 2.6 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.9 | 5.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.9 | 3.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.8 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.8 | 1.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.8 | 1.7 | GO:1901658 | glycoside catabolic process(GO:0016139) glycosyl compound catabolic process(GO:1901658) |
| 0.8 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.8 | 13.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.8 | 5.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 4.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.8 | 2.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.8 | 3.3 | GO:0048749 | compound eye development(GO:0048749) |
| 0.8 | 2.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.8 | 4.1 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
| 0.8 | 4.9 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.8 | 2.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.8 | 1.6 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.8 | 4.0 | GO:0044336 | embryonic genitalia morphogenesis(GO:0030538) canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.8 | 11.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.8 | 6.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.8 | 2.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.8 | 3.2 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.8 | 8.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.8 | 1.6 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.8 | 2.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |